F-Prime backed startup nabs another $50M in bid to scale up AI R&D software
Almost two years after getting an infusion of cash from F-Prime and other big investors, Toronto biotech BenchSci is back with more money in its coffers — and plans for expansion.
The AI software startup, which last raised $22 million in a 2020 Series B, announced that it now has raised $50 million in a Series C this morning, led by previous investor Inovia Capital and new investor TCV. Inovia also led the startup’s original Series A raise. With the round now putting the company at $97 million raised, it gives the biotech more breathing room to expand.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.